Need a specific person's email?
Browse CREATE Medicines's employee directory (about 45 employees) and reveal verified emails free.
CREATE Medicines's most common email format is FLast@myeloidtx.com (ex. JDoe@myeloidtx.com), used for 93% of myeloidtx.com addresses. CREATE Medicines uses 5 email patterns across 2 domains: myeloidtx.com and createmedicines.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of myeloidtx.com |
|---|---|---|
| FLast@myeloidtx.comMost common | JDoe@myeloidtx.com | |
| FMiddleLast@myeloidtx.com | JMichaelDoe@myeloidtx.com | |
| First@myeloidtx.com | John@myeloidtx.com | |
| FirstLast@myeloidtx.com | JohnDoe@myeloidtx.com |
| Format | Example | Share of createmedicines.com |
|---|---|---|
| FLast@createmedicines.comMost common | JDoe@createmedicines.com |
Browse CREATE Medicines's employee directory (about 45 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States11-50 Employees
CREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on in vivo programming of immune responses across multiple pathways. It operates a proprietary platform that delivers mRNA-based instructions to immune cells inside the body, enabling scalable, repeat-dose, off-the-shelf immunotherapies. This approach underpins a pipeline of in vivo CAR therapies aimed at improving outcomes in cancer, autoimmune diseases, and fibrosis. The company concentrates on oncology while autoimmune programs remain in preclinical testing. Recent updates highlight MT-302 as a candidate for TROP2-expressing cancers, including potential first-line use in gastroesophageal junction carcinoma.
Most common format
FLast@myeloidtx.com
Example: JDoe@myeloidtx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.